OmniBioPro
partners with biotechnology, pharmaceutical companies, academic institutions, CROs, CDMOs, and innovators to deliver groundbreaking solutions that address global healthcare challenges. Founded in 2019 by industry-leading scientists, OmniBioPro combines scientific precision, strategic insights, and operational excellence to create impactful results for patients and businesses.
We specialize in all stages of the healthcare lifecycle—from discovery and development to commercialization and beyond. With expertise across vaccines, biologics, cell and gene (CGT), antibody-drug conjugates (ADCs), RNA, DNA, peptides, oligonucleotides, small molecules, domain antibodies, liposomes, nanoparticles, bispecifics, fusion proteins, biosimilars, biobetters, blood plasma-derived, exosomes, gene editing, radiopharmaceuticals, and advanced delivery platforms or devices, we tailor solutions that empower our partners to achieve measurable success.
Our collaborations span research institutions, startups, small enterprises, and global industry leaders, providing support across every stage of development. We are uniquely positioned to bridge the gap between science and business to reach your goals by offering comprehensive solutions include:
- CMC Excellence & Supply Chain Management
- Regulatory Guidance & Compliance
- Product Innovation & Development
- Clinical Trials & Operational Support
- Technology Transfer & Process Validation
- Intellectual Property Strategy
- Training & Development Programs
- Strategic Advisory & Market Expansion
- Mergers, Acquisitions, and Structuring
- Legal Services
Commitment: OmniBioPro upholds the highest standards of confidentiality, integrity, and quality, ensuring that your innovations are protected, and your goals are achieved.
Our Company
OmniBioPro – Your Trusted Partner in Healthcare Innovation
Subheadline: Combining Scientific Precision with Strategic Expertise to Drive Global Impact
OmniBioPro is more than a solution provider—we’re your strategic partner in revolutionizing healthcare innovation. With decades of global experience, we specialize in bridging the gap between science and business, helping our partners overcome the complexities of modern healthcare challenges, from molecules to medicine and helping patients.
Our expertise encompasses all types of modalities from vaccine, therapeutic, and diagnostic, including biologics, CGT, ADCs, mRNA, oligo, small molecules, RPT, and advanced combinational products such as viral and non-viral delivery platforms.
From early discovery to post-market lifecycle management, OmniBioPro drives success through end-to-end solutions tailored to every stage of development. Additionally, we also specialize in corporate structuring, training programs, legal advisory, and operational streamlining to address client-specific needs comprehensively. All is transcribed by our OmniBioPro’s DNA of unwavering commitment to innovation, confidentiality, and client success. We have a unique blend of scientific excellence with business acumen, we ensure our clients thrive in a competitive, evolving healthcare ecosystem.
What We Do
Accelerating Innovation Across the Healthcare Lifecycle
From Discovery to Commercialization, OmniBioPro Delivers Results
At OmniBioPro, we specialize in bridging the gap between science and strategy to deliver tailored solutions for every stage of healthcare innovation. Whether it's identifying promising candidates, optimizing processes, navigating regulatory landscapes, or driving commercialization, our expertise ensures your success.
Our Approach
From discovery to commercialization, we provide end-to-end solutions that empower our clients to innovate, grow, and succeed in a competitive global market. Our collaborative approach ensures tailored strategies, integrating expertise in preclinical research, GMP manufacturing, market strategy development, regulatory compliance, and more.
What Sets Us Apart:
- Innovation: Embracing cutting-edge science to solve the toughest challenges.
- Collaboration: Building lasting partnerships through trust and transparency.
- Integrity: Upholding confidentiality, ethical practices, and excellence.
- Global Impact: Delivering solutions that improve lives worldwide.
Our Mission
To advance global healthcare by delivering innovative products, tailored solutions, expert guidance, and strategic insights. At OmniBioPro, we empower our partners to achieve technical excellence, streamline operations, and accelerate the journey from concept to market—all while upholding the highest standards of integrity, quality, and trust. Grounded in integrity, collaboration, and innovation, OmniBioPro delivers tailored solutions to drive transformative healthcare progress
Our Vision
To be a global leader in healthcare innovation, shaping the future of medicine through transformative solutions that have a lasting impact on global health.
Why OmniBioPro?
At OmniBioPro, we provide more than solutions—we deliver enduring impact. Our unparalleled expertise and commitment to excellence empower our partners across the healthcare and life sciences landscape.
- Proven Expertise: Decades of combined operational and leadership experience.
- Qualified & Experienced Specialists: Collaborate With Us to Enhance Biopharma Development and Achieve Your Business Goals Efficiently
- Multi-Modality Proficiency: Expertise across biologics, CGT, ADCs, and more.
- End-to-End Solutions: Tailored services designed to meet unique client needs.
- Global Reach: Supporting clients across the U.S., EU, MENA, and beyond.
Leadership
Visionary Leadership Anchored in Expertise and Excellence
Leadership at OmniBioPro is defined by a steadfast commitment to excellence, innovation, and collaboration. Our founder and Chief Technology Officer, Dr. Wasfi Alazzam, Ph.D., brings decades of global leadership experience in pharmaceutical and biotechnology innovation. Dr. Alazzam’s distinguished career includes senior roles at renowned organizations like Regeneron, Takeda, GSK, and Bayer Healthcare (now Grifols), where he spearheaded advancements in Chemistry, Manufacturing, and Controls (CMC), regulatory compliance, and clinical trial operations.
Leadership That Drives Innovation
Career Highlights
- Global Team Leadership: Built and managed cross-functional teams and business units across diverse global markets, fostering collaboration and operational excellence.
- Extensive Product Development: Contributed to the development and commercialization of hundreds of products across modalities like biologics, CGT, ADCs, radiopharmaceuticals, and more.
- Strategic Initiatives: Played a pivotal role in mergers, acquisitions, due diligence, and the integration of innovative healthcare technologies.
- Conference Leadership: Founded, chaired, and led conference initiatives, sharing insights on cutting-edge advancements.
Beyond his technical prowess, Dr. Alazzam has played a pivotal role in driving organizational success through strategic initiatives, such as supporting mergers and acquisitions, conducting extensive due diligence on emerging technologies, assets, and partnerships, and advancing innovative healthcare technologies in hardware and software integration.
Dr. Alazzam is also a prolific thought leader, having co-authored numerous peer-reviewed publications, clinical trial reports, and patents. His reputation as a sought-after speaker has seen him deliver high-impact keynotes and workshops at leading international conferences. Furthermore, his dedication to mentoring and advising startups, emerging companies, and research institutions underscores his commitment to fostering the next generation of healthcare innovation.
Under Dr. Alazzam’s visionary leadership, OmniBioPro seamlessly integrates science, strategy, and execution to deliver transformative solutions, setting new standards in the healthcare and bio-pharmaceutical sectors.
